ReShape Lifesciences Company Overview

ReShape Lifesciences logo
ReShape Lifesciences
ReShape Lifesciences primary media

About ReShape Lifesciences

ReShape Lifesciences (NASDAQ:RSLS) specializes in developing and commercializing innovative medical devices and services for managing and treating obesity and metabolic diseases. This company focuses on providing patients with comprehensive, life-changing solutions that address the global obesity epidemic through their lineup of products, including minimally invasive surgical devices and non-surgical weight loss solutions. Their projects often involve extensive research and development aimed at enhancing the safety, effectiveness, and accessibility of weight management options. ReShape Lifesciences' primary objective is to improve the health and quality of life for those struggling with obesity, aiming to deliver sustainable and transformative treatments. The company's commitment to advancing obesity care through innovation positions it as a key player in the medical device sector.

What is ReShape Lifesciences known for?

Snapshot

2002
Year founded
29
Employees
San Clemente, United States
Head office
Loading Map...

Operations

All Locations
San Clemente, US

Produtos e/ou serviços de ReShape Lifesciences

  • LAP-BAND Adjustable Gastric Banding System for weight loss management through minimally invasive surgery.
  • ReShape Vest, an investigational, minimally invasive, laparoscopically implanted device designed to aid in weight loss.
  • ReShape Care, a virtual health coaching service that supports weight loss and weight management patients with personalized coaching.
  • ReShape Marketplace, offering dietary supplements and meal replacements tailored for individuals undergoing or considering weight management treatments.
  • Reshape Gastric Balloon, a non-surgical weight loss solution involving a balloon placed in the stomach to occupy space and promote a feeling of fullness.

equipe executiva do ReShape Lifesciences

  • Mr. Dan W. GladneyExecutive Chair
  • Mr. Paul F. HickeyCEO, President & Director
  • Mr. Thomas StankovichSenior VP & CFO
  • Mr. Al DiazVice President of Operations and R&D
  • Dr. Dov Gal D.V.M., M.B.A.VP of Regulatory Clinical Quality & Compliance Officer
  • Mr. Naqeeb A. AnsariSenior Vice President of Global Commercial Operations

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.